 Comparison SPECT agents PET assessment myocardial perfusion viability report applications tomographic current new tracers myocardial perfusion viability Multiple studies single photon emission tomography SPECT detection coronary artery disease CAD high sensitivity high rates normalcy high reproducibility viability defects viable zones studies Redistribution hours injection reinjection redistribution imaging accuracy viability assessment SPECT studies suboptimal physical properties variable image quality new myocardial perfusion tracers ability amounts radioactivity possible ventricular function myocardial perfusion injection radiotracer sestamibi slow myocardial clearance prolonged imaging time results image quality superior teboroxime combination minimal redistribution sestamibi high count rates gated SPECT imaging feasible assessment patients acute ischemic syndromes time injection time combination high image quality first-pass exercise capabilities choice agent assessment chronic CAD